Alpha 1-antitrypsin deficiency primary prevention: Difference between revisions
Mazia Fatima (talk | contribs) |
Mazia Fatima (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Effective measures for the primary prevention of alpha 1-antitrypsin deficiency includes vaccination against hepatitis A and B is recommended to decrease the risk of liver disease. | |||
==Primary Prevention== | ==Primary Prevention== | ||
Revision as of 22:45, 12 December 2017
|
Alpha 1-antitrypsin deficiency Microchapters |
|
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Alpha 1-antitrypsin deficiency primary prevention On the Web |
|
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency primary prevention |
|
Alpha 1-antitrypsin deficiency primary prevention in the news |
|
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
|
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Effective measures for the primary prevention of alpha 1-antitrypsin deficiency includes vaccination against hepatitis A and B is recommended to decrease the risk of liver disease.
Primary Prevention
Effective measures for the primary prevention of alpha 1-antitrypsin deficiency include:
- Vaccination against hepatitis A and B is recommended to decrease the risk of liver disease.